Systemic ototoxicity: A review

East African Medical Journal

Volumn 82, Issue 10, 2005, Pages 536-539

  Shine, N P ^a,b   Coates, H ^a  

^a PRINCESS MARGARET HOSPITAL FOR CHILDREN   (Australia)

^b NONE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOGLYCOSIDE; ANTIMALARIAL AGENT; DIURETIC AGENT; FUROSEMIDE; QUININE;

AFRICA SOUTH OF THE SAHARA; CHEMICALLY INDUCED DISORDER; DRUG TOXICITY; HEARING LOSS; HUMAN; REVIEW; RISK ASSESSMENT; RISK FACTOR; VESTIBULOCOCHLEAR NERVE DISEASE;

AFRICA SOUTH OF THE SAHARA; AMINOGLYCOSIDES; ANTIMALARIALS; DIURETICS; DRUG TOXICITY; FUROSEMIDE; HEARING LOSS; HUMANS; QUININE; RISK ASSESSMENT; RISK FACTORS; VESTIBULOCOCHLEAR NERVE DISEASES;

EID: 33644942683     PISSN: 0012835X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (27)

1. Hawkins, J. E. Drug ototoxicity. In: Keidel, W. D., Neff, W. D. eds. Handbook of sensory physiology. Berlin: Springer-Verlag, 1976; 5:707-748.
2. Minja, B. M. Aetiology of deafness among children at the Buguruni School for the Deaf in Dar es Salaam, Tanzania. Int. J. Pediatr. Otorhinolaryngol. 1998; 42:225-231.
3. Chukuezi, A. B. Profound and total deafness in Owerri, Nigeria. East. Afr. Med. J. 1991; 68:905-912.
4. Chiodo, A. A. and Alberti, P. W. Experimental, clinical and preventive aspects of ototoxicity. Eur. Arch Otorhinolaryngol 1994; 251:375-392.
5. Brummett, R. E. and Morrison, R. B. The incidence of aminoglycoside antibiotic-induced hearing loss. Arch Otolaryngol Head Neck Surg. 1990; 116:406-410
6. Neilsen-Abbring, F. W., Perenboom, R. M. and Van der Hulst, R. J. Quinine induced hearing loss. ORL. 1990; 52:65-68.
7. Prepageran, N. and Rutka, J. A. Salicylates, nonsteroidal anti-inflammatory drugs, quinine, and heavy metals. In: Ototoxicity, Roland P. S., Rutka, J. A. (eds), B. C Decker Inc, Hamilton, London 2004.
8. Claessen, F. A., van Boxtel, C. J, Perenboom R. M. et al. Quinine pharmacokinetics: ototoxic and cardiotoxic effects in healthy Caucasian subjects and in patients with falciparum malaria. Trop. Med. Int. Health. 1998; 3:482-489.
9. Tange, R. A., Dreschler, W. A., Claessen, F. A. and Perenboom, R. M. Ototoxic reactions of quinine in healthy persons and patients with Plasmodium falciparum infection. Auris. Nasus. Larynx. 1997; 24:131-136.
10. Jung, T. K., Rhee, C. K., Lee, C. S. et al. Ototoxicity of salicylate, nonsteroidal anti-inflammatory drugs and quinine. Otolaryngol Clin. North. Amer. 1993; 26:791-810.
11. Matz, G. J. Aminoglycoside cochlear ototoxicity. Otolaryngol Clin. North. Amer. 1993; 26:705-712.
12. Bates, D. E., Beaumont, S. J. and Baylis, B. W. Ototoxicity induced by gentamicin and furosemide. Ann Pharmacother. 2002; 36:446-450.
13. Huy, P. T. B, Bernard, P. and Schacht, J. Kinetics of gentamicin uptake and release in the rat. J. Clin. Invest. 1986; 77:1492-1500.
14. Fischel-Ghodsian, N., Prezant, T. R., Chaltraw, W. E. et al. Mitochondrial gene mutation is a significant predisposing factor in aminoglycoside ototoxicity. Amer. J. Otolaryngol 1997; 18:173-178.
15. Fee, W. Aminoglycoside ototoxicity in the human. Laryngoscope 1980; 24:1-19.
16. Black, F. O. and Pesznecker, S. C. Vestibular ototoxicity: clinical considerations. Otolaryngol Clin. North. Amer. 1993; 26:713-736.
17. Rutka, J. A. Physiology of the vestibular system. In: Ototoxicity, Roland, P. S, Rutka, J. A. (eds), B. C., Decker Inc, Hamilton, London 2004.
18. Chambers, B. R., Mai, M. and Barber, H. O. Bilateral vestibular loss, oscillopsia and the cervico-ocular reflex. Otolaryngol Head Neck Surg. 1985; 93:403-407.
19. Hatala, R., Dinh, T. and Cook, D. J. Once-daily aminoglycoside dosing in immunotompetent adults: a meta-analysis. Ann. Intern. Med. 1996; 124:717-725.
20. Bailey, T. C., Little, J. R., Littenberg, B. et al. A meta-analysis of extended-interval dosing versus multiple daily dosing of aminoglycosides. Clin. Infect. Dis. 1997; 24: 786-795.
21. Moore, R. D., Smito, C. R. and Lietmao, P. S. Risk factors for development of auditory toxicity in patients receiving aminoglycosides. J. Infect. Dis. 1984; 134:8206-218.
22. Lloyd-Mostyn, R. M. and Lord, I. J. Ototoxicity of intravenous frusemide. Lancet. 1971; 2:1156.
23. Morelli, O. H., Moledo, L. I. and Alanis, E. Acute effects of high doses of furosemide in patients with chronic renal failure. Postgrad. Med. J. 1971; 47:29-35.
24. Quick, C. A. and Hoppe, W. Permanent deafness associated with furosemide administration. Ann. Otol. 1975; 84: 94-101.
25. Wigand, M. E. and Heidland, A. Ototoxic side effects of high doses of furosemide in patients with uremia. Postgrad. Med. J. 1971; 47(supp):54-56.
26. Rybak, L. P. Ototoxicity of loop diuretics. Otolaryngol. Clin. North. Amer. 1993; 26:829-844.
27. Brummett, R. E. Drug induced ototoxicity. Drugs. 1980; 19:412-428.